Sun Pharmaceutical Industries Ltd. Stock price

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Market Closed - NSE India S.E. 08:02:01 2024-03-28 am EDT 5-day change 1st Jan Change
1,621 INR +1.02% Intraday chart for Sun Pharmaceutical Industries Ltd. +3.54% +28.67%
Sales 2024 * 485B 5.82B Sales 2025 * 538B 6.46B Capitalization 3,888B 46.65B
Net income 2024 * 93.16B 1.12B Net income 2025 * 112B 1.35B EV / Sales 2024 * 7.79 x
Net cash position 2024 * 108B 1.3B Net cash position 2025 * 166B 2B EV / Sales 2025 * 6.91 x
P/E ratio 2024 *
41.8 x
P/E ratio 2025 *
34.6 x
Employees 41,000
Yield 2024 *
0.75%
Yield 2025 *
0.87%
Free-Float 45.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.02%
1 week+3.54%
Current month+2.70%
1 month+2.97%
3 months+28.40%
6 months+43.12%
Current year+28.67%
More quotes
1 week
1 592.10
Extreme 1592.1
1 634.00
1 month
1 520.50
Extreme 1520.5
1 634.00
Current year
1 257.15
Extreme 1257.15
1 634.00
1 year
922.45
Extreme 922.45
1 634.00
3 years
587.25
Extreme 587.25
1 634.00
5 years
312.00
Extreme 312
1 634.00
10 years
312.00
Extreme 312
1 634.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder 68 81-12-31
Director of Finance/CFO - 17-06-18
Members of the board TitleAgeSince
Founder 68 81-12-31
Director/Board Member 67 21-05-20
Director/Board Member 63 23-06-14
More insiders
Date Price Change Volume
24-03-28 1,621 +1.02% 4,427,587
24-03-27 1,604 +0.38% 2,530,169
24-03-26 1,598 -0.67% 3,649,049
24-03-22 1,609 +2.79% 4,941,447
24-03-21 1,565 +1.02% 2,567,975

Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT

More quotes
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,621 INR
Average target price
1,541 INR
Spread / Average Target
-4.88%
Consensus
  1. Stock
  2. Equities
  3. Stock Sun Pharmaceutical Industries Ltd. - NSE India S.E.